01652 FUSEN PHARM
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.60X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 21.4% | Net Margin | N/A |
| Total Debt/Equity | 103.8% | Return on Equity | N/A |
| Price/Book | 0.63X | Return on Assets | N/A |
| (HKD 0.335) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -200.77 | -39.98 | -38.80 | 20.36 | 83.23 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -402.1 | -3.1 | -290.6 | -75.5 | +39.3 |
| Earnings Per Share (HKD) | -0.271 | -0.053 | -0.051 | 0.027 | 0.106 |
| Earnings Per Share Growth (%) | -410.0 | -3.7 | -293.6 | -75.0 | +41.8 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.011 | 0.011 |
| P/E* (X) | N/A | N/A | N/A | 12.64 | 3.16 |
| Yield (%) | N/A | N/A | N/A | 3.28 | 3.13 |
| Dividend Share (%) | N/A | N/A | N/A | 41.51 | 9.92 |
| Book NAV (HKD) | 0.532 | 0.828 | 0.908 | 1.046 | 1.011 |
| Auditors' Opinion | Unqualified # | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 326.029 | 565.608 | -42.4 | 491.757 |
| Operating Result | -86.352 | -8.032 | +975.1 | -8.307 |
| Associates | -104.097 | -20.292 | +413.0 | -21.019 |
| Profit Before Taxation | -190.446 | -29.448 | +546.7 | -30.993 |
| Taxation | -1.646 | 6.847 | -124.0 | 3.661 |
| Profit /( Loss) After Taxation | -188.8 | -36.295 | +420.2 | -34.654 |
| Minority Interests | -0.017 | -0.018 | -5.6 | -0.049 |
| Net Profit | -188.783 | -36.277 | +420.4 | -34.605 |
| Earnings Per Share () | -0.2713 | -0.0532 | +410.0 | -0.0513 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
